Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07698756
PHASE1

A Clinical Study of HRS-8797 in Healthy Participants

Sponsor: Chengdu Suncadia Medicine Co., Ltd.

View on ClinicalTrials.gov

Summary

The purpose of this phase I study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-8797 in healthy participants.

Official title: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect Following Single and Multiple Oral Doses of HRS-8797 Tablets in Healthy Subjects

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

74

Start Date

2026-07

Completion Date

2027-01

Last Updated

2026-07-13

Healthy Volunteers

Yes

Interventions

DRUG

HRS-8797

Specified dose on specified days

DRUG

Placebo

Specified dose on specified days

Locations (1)

The First Hospital of Jilin University

Changchun, Jilin, China